Status:
COMPLETED
Survey of Cannabis Use in Patients With Chronic Inflammatory Arthritis
Lead Sponsor:
University Hospital, Clermont-Ferrand
Conditions:
Rheumatoid Arthritis
Ankylosing Spondylitis
Eligibility:
All Genders
18+ years
Brief Summary
Patients with inflammatory rheumatism very often have residual pain that is not easily relieved by conventional treatments. They can then use non-drug methods, such as physiotherapy, hypnosis or even ...
Detailed Description
Thanks to a better understanding of the pathophysiological mechanisms of inflammatory rheumatism, rheumatology has known for several decades a growth in its therapeutic arsenal (csDMARDs, bDMARDs, tDM...
Eligibility Criteria
Inclusion
- Rheumatoid Arthritis (ACR 2010 Criteria)
- Ankylosing Spondylitis (New york or ASAS criteria)
- Psoriatic Arthritis (CASPAR criteria)
Exclusion
- Patient unable to complete questionnaires or unable to express informed consent
- Guardianship, trusteeship, deprivation of liberties, safeguard of justice
Key Trial Info
Start Date :
May 19 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 19 2021
Estimated Enrollment :
501 Patients enrolled
Trial Details
Trial ID
NCT04402554
Start Date
May 19 2020
End Date
March 19 2021
Last Update
June 2 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu Clermont Ferrand
Clermont-Ferrand, France, 63003